Profile
Dalriada is a leading North American partnered discovery company that is pioneering its novel Turn-Key™ model in small molecule drug discovery. Purpose-built and partner-centric, the organization integrates world-class expertise across synthetic, medicinal, and computational chemistry; structural and in vitro biology; chemoproteomics; and discovery strategy—enabling and accelerating even the most challenging programs from inception. As part of its commitment to innovation, Dalriada also offers iCLASS, a revolutionary TechBio platform that merges multi-proteomics-centered data generation with next-generation machine learning. iCLASS establishes a new vertical in drug discovery, unlocking biologically relevant and highly translatable insights to maximize R&D efficiency—promising zero-dollar loss per R&D dollar invested. With a robust portfolio of early-stage assets, including programs targeting previously "undruggable" mechanisms, iCLASS is reshaping what’s possible in drug discovery.
Product/Service Information:
The typical end users of Dalriada’s services include pharmaceutical and biotechnology companies, as well as emerging scientific ventures engaged in or reliant on early-stage small-molecule drug discovery research. Its partners span a range of therapeutic areas and modalities and leverage Dalriada’s expertise to accelerate hit identification, target validation, and lead optimization efforts.
Website
dalriadatx.comContact
-
Mohammad Eram, Senior Director, Discovery R&DTel: +1 416-566-5415Email: mohammad.eram@dalriadatx.com
-
-
-
-
-
-
Diana Kraskouskaya, Chief Executive Officer and Co-founderTel: +1 647-860-7948Email: diana@dalriadatx.com
-
-
-
-
-
Event details
Event contact
Participants
-
ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for life… -
Copoly.ai is a Canadian biotechnology and AI company redefining early cancer detection… -
Dalriada is a leading North American partnered discovery company that is pioneering its novel Turn-Key™ model in small… -
DistillerSR is the leading platform for AI powered literature review automation and evidence… -
Northern Vascular Systems (NVS) has pioneered a novel, light-activated gel for treatment of vascular… -
Rapid Novor Inc. is a leading CRO specializing in antibody…